These findings together with the published data suggest that serum and ascites levels of VEGF could serve as a predictive or prognostic biomarker in studies involving MA animal models or MA patients (Fushida et al., 2013; Bhaskari and Krishnamoorthy, 2015). Here, VEGFA is linked to microtia.